Most community monitoring protocols draw IGF-1 either pre-cycle or 2-4 weeks post-cycle
Many patients in the United States report experiencing a dry mouth, uncharacteristic fatigue, mild headaches, or an intensified sensation of thirst within the first few weeks of escalating their dose
This heterogeneity may be attributed to differences in baseline HbA1c levels, obesity prevalence, trial duration, comparator treatments, dosing strategies, and outcome definitions
Anyone considering it in a research setting should do so with careful monitoring, especially if combining with other sleep or hormone-related compounds
Endocrine 59(2):260274 Pontzer H, Durazo-Arvizu R, Dugas LR, Plange-Rhule J, Bovet P, Forrester TE, Lambert EV, Cooper RS, Schoeller DA, Luke A (2016) Constrained total energy expenditure and metabolic adaptation to physical activity in adult humans
By day 35, it falls to approximately 60 percent, making the solution effectively unusable for research purposes